Casero R A, Celano P, Ervin S J, Wiest L, Pegg A E
Johns Hopkins Oncology Center Laboratories, Johns Hopkins School of Medicine, Baltimore, MD 21231.
Biochem J. 1990 Sep 15;270(3):615-20. doi: 10.1042/bj2700615.
The cytotoxic response of the human large cell lung carcinoma line NCI H157 to exposure to the polyamine analogue N1 N12-bis(ethyl)spermine (BESpm) is preceded by an extremely high induction of spermidine/spermine N1-acetyltransferase (SSAT). The human enzyme has now been purified greater than 300-fold to apparent homogeneity and found to cross-react with antisera raised against rat liver SSAT. Although other acetylases are capable of acetylating polyamines using acetyl-CoA as the acetyl donor, the greater than 600-fold induction within 24 h was found to be specifically SSAT, since essentially all activity was precipitable by the specific antisera. The human enzyme appears to be similar to the rat enzyme in subunit size under reducing conditions (approximately 20 kDa), substrate specificity and kinetic parameters. Preliminary results using actinomycin D and cycloheximide suggested that the unusually high induction by N1 N12-bis(ethyl)spermine in the human lung cancer line result from new mRNA and protein synthesis. This hypothesis is further substantiated here by 'in vitro' translation experiments comparing poly(A) mRNA from control and treated cells. The large cell lung carcinoma line NCI H157 represents a useful system to produce large amounts of the SSAT protein and to study the molecular events responsible for the induction and control of this important polyamine-metabolic enzyme. By using this rich source of SSAT protein, a partial amino acid sequence was determined by N-terminal sequencing of endoproteinase Lys-C digestion fragments. Further, this system should be useful in determining whether there is an association between the unusually high induction of the acetylase and the observed cytotoxicity in the NCI H157 cells.
人肺大细胞癌系NCI H157在暴露于多胺类似物N1,N12-双(乙基)精胺(BESpm)后出现细胞毒性反应,在此之前,亚精胺/精胺N1-乙酰转移酶(SSAT)的诱导水平极高。现在,人源酶已被纯化至表观均一性,纯化倍数超过300倍,并发现其与针对大鼠肝脏SSAT产生的抗血清发生交叉反应。尽管其他乙酰化酶能够利用乙酰辅酶A作为乙酰供体对多胺进行乙酰化,但发现在24小时内超过600倍的诱导是特异性的SSAT,因为基本上所有活性都可被特异性抗血清沉淀。在还原条件下,人源酶在亚基大小(约20 kDa)、底物特异性和动力学参数方面似乎与大鼠酶相似。使用放线菌素D和环己酰亚胺的初步结果表明,人肺癌细胞系中N1,N12-双(乙基)精胺的异常高诱导是由新的mRNA和蛋白质合成引起的。通过比较对照细胞和处理细胞的多聚(A)mRNA进行的“体外”翻译实验进一步证实了这一假设。人肺大细胞癌系NCI H157是一个有用的系统,可用于大量生产SSAT蛋白,并研究负责诱导和控制这种重要多胺代谢酶的分子事件。通过利用这种丰富的SSAT蛋白来源,通过对蛋白酶Lys-C消化片段进行N端测序确定了部分氨基酸序列。此外,该系统应有助于确定乙酰化酶的异常高诱导与NCI H157细胞中观察到的细胞毒性之间是否存在关联。